J. Joseph Kim
-
Plymouth Meeting Biopharma Co. Turns Focus Inward to Heal Itself by Cutting Costs
Plymouth Meeting biopharma firm Inovio, working to cure its own ills, is undergoing a reorg. The multiple measures it is…
-
Plymouth Meeting-based Inovio Replaces CEO, Switches Focus from COVID-19 Vaccine to Developing Booster
Plymouth Meeting-based Inovio has replaced co-founder J. Joseph Kim as CEO and announced that it will shift its focus from…
-
Thermo Fisher Scientific to Manufacture Inovio’s DNA-Based COVID-19 Vaccine
Plymouth Meeting-based Inovio has signed a manufacturing deal with Thermo Fisher for its experimental DNA-based Covid-19 vaccine candidate, writes John…
-
Plymouth Meeting-Based Inovio Within Reach of COVID-19 Vaccine Breakthrough
With the DNA technology Inovio is basing its COVID-19 vaccine on still experimental after nearly four decades of research and…
-
Plymouth Meeting-Based Inovio Pharmaceuticals Receives Grant to Develop Vaccine for Newly Identified Coronavirus in China
Plymouth Meeting-based Inovio Pharmaceuticals has been awarded a grant of up to $9 million to rapidly develop a vaccine for…
-
Plymouth Meeting’s Inovio Pharmaceuticals Starts Testing Zika Vaccine in Puerto Rico
Plymouth Meeting’s Inovio Pharmaceuticals has started a clinical study of its experimental Zika vaccine on 160 healthy adult volunteers in…
-
Plymouth Meeting’s Inovio Pharmaceuticals Tests Zika Vaccine on First Volunteer
Plymouth Meeting’s Inovio Pharmaceuticals has injected the first volunteer with its experimental vaccine for the Zika virus, with results from…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
